help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalra, S. P.
Right arrow Articles by Crowley, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalra, S. P.
Right arrow Articles by Crowley, W. R.

Endocrinology, Vol 130, 3323-3330, Copyright © 1992 by Endocrine Society


ARTICLES

Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats

SP Kalra, M Fuentes, A Fournier, SL Parker and WR Crowley
Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville 32610.

The present experiments were designed to investigate structure-function relationships, and identify the receptor subtype and postreceptor cellular mechanisms that mediate the ovarian hormone-dependent, excitatory, and inhibitory effects of neuropeptide Y (NPY) on LH release in female rats. Intracerebroventricular administration of NPY decreased plasma concentrations of LH in ovariectomized, hormonally untreated rats but stimulated LH release in ovariectomized rats pretreated with estradiol benzoate and progesterone. A similar dual response was also obtained after administration of NPY2-36. However, deletion of additional amino acids at the N terminus, as in NPY5-36, NPY11-36, NPY16-36, and NPY25-36, rendered the peptides inactive. An N- terminal fragment, NPY1-24-amide, and a discontinuous NPY analog, NPY1- 4-epsilon-amino-caproic acid-25-36, similarly failed to influence LH release. The analog [Leu31,Pro34]NPY, a preferential agonist at the Y-1 NPY receptor subtype, also elicited the dual LH responses, but the preferential Y-2 receptor agonist, NPY13-36, was completely inactive. Further, only the peptides that stimulated LH release in vivo, i.e. NPY, NPY2-36, and [Leu31,Pro34]NPY, also stimulated the release of LHRH from median eminence fragments of steroid-primed rats in vitro, and the excitatory effect of [Leu31,Pro34] NPY was blocked by a noncompetitive NPY receptor antagonist, D-myo-inositol-1,2,6-trisphosphate. With the exception of NPY1-24-amide, all of the NPY fragments tested bound specifically to NPY binding sites in hypothalamic membrane preparations, but the highest binding affinities were found for the peptides that evoked biological responses in the in vivo and in vitro tests. Further analysis of the mode of action of NPY showed that the stimulation of LHRH release in vitro was unaffected by omission of Ca2+ from the incubation medium, but was prevented by two antagonists of intracellular Ca2+ mobilization, 3,4,5-trimethoxybenzoic acid 8- (diethylamino)octyl ester and ryanodine. Inhibition of prostaglandin synthesis with indomethacin blocked the stimulatory effect of the alpha 1-adrenergic agonist methoxamine on LHRH release, but not the increase produced by NPY.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. H. Mills, R. K. Sohn, and P. E Micevych
Estrogen-Induced {micro}-Opioid Receptor Internalization in the Medial Preoptic Nucleus Is Mediated via Neuropeptide Y-Y1 Receptor Activation in the Arcuate Nucleus of Female Rats
J. Neurosci., January 28, 2004; 24(4): 947 - 955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. S. Corp, B. Greco, J. B. Powers, C. L. M. Bivens, and G. N. Wade
Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1061 - R1068.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. J. Small, M. S. Kim, S. A. Stanley, J. R.D. Mitchell, K. Murphy, D. G.A. Morgan, M. A. Ghatei, and S. R. Bloom
Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals
Diabetes, February 1, 2001; 50(2): 248 - 254.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Xu, J. H. Urban, J. W. Hill, and J. E. Levine
Regulation of Hypothalamic Neuropeptide Y Y1 Receptor Gene Expression during the Estrous Cycle: Role of Progesterone Receptors
Endocrinology, September 1, 2000; 141(9): 3319 - 3327.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
F. Sun and J. Yu
The Effect of a Special Herbal Tea on Obesity and Anovulation in Androgen-Sterilized Rats
Experimental Biology and Medicine, March 1, 2000; 223(3): 295 - 301.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. R. Jain, S. Pu, P. S. Kalra, and S. P. Kalra
Evidence that Stimulation of Two Modalities of Pituitary Luteinizing Hormone Release in Ovarian Steroid-Primed Ovariectomized Rats May Involve Neuropeptide Y Y1 and Y4 Receptors
Endocrinology, November 1, 1999; 140(11): 5171 - 5177.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Li, P. Chen, and M. S. Smith
Morphological Evidence for Direct Interaction between Arcuate Nucleus Neuropeptide Y (NPY) Neurons and Gonadotropin-Releasing Hormone Neurons and the Possible Involvement of NPY Y1 Receptors
Endocrinology, November 1, 1999; 140(11): 5382 - 5390.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert
Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype
Endocrinology, September 1, 1999; 140(9): 4046 - 4055.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley
Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Li, P. Chen, and M. S. Smith
The Acute Suckling Stimulus Induces Expression of Neuropeptide Y (NPY) in Cells in the Dorsomedial Hypothalamus and Increases NPY Expression in the Arcuate Nucleus
Endocrinology, April 1, 1998; 139(4): 1645 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Small, D. G. A. Morgan, K. Meeran, M. M. Heath, I. Gunn, C. M. B. Edwards, J. Gardiner, G. M. Taylor, J. D. Hurley, M. Rossi, et al.
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release
PNAS, October 14, 1997; 94(21): 11686 - 11691.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Chen and A. N. van den Pol
Multiple NPY Receptors Coexist in Pre- and Postsynaptic Sites: Inhibition of GABA Release in Isolated Self-Innervating SCN Neurons
J. Neurosci., December 1, 1996; 16(23): 7711 - 7724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Ball, J. Shine, and H. Herzog
Multiple Promoters Regulate Tissue-specific Expression of the Human NPY-Y1 Receptor Gene
J. Biol. Chem., November 10, 1995; 270(45): 27272 - 27276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society